20 CSR 2220-7.040 - Foreign Graduates
PURPOSE: This rule establishes licensure requirements for pharmacist applicants who are graduates from a pharmacy school/college not located in the United States or a United States territory.
(1) Definitions.
(A) Foreign school/college-For purposes of
this rule, a foreign school/college shall be defined as a school/college of
pharmacy that is not located in a United States (U.S.)
state/territory.
(B) Preliminary
evaluation application- The Application for Preliminary Evaluation of Foreign
Pharmacy School Graduate provided by the board for graduates of a foreign
school/college.
(2)
Applicability. The provisions of this rule are applicable to all graduates of a
foreign school/college, including, graduates currently or previously licensed
as a pharmacist by another U.S. state/territory. Graduates from a foreign
school/college of pharmacy shall comply with the provisions of this rule prior
to filing an examination application, an application for pharmacist licensure,
or a reciprocity application.
(3)
Prior to applying for pharmacist licen-sure/examination, graduates of a foreign
school/college shall first obtain Foreign Pharmacy Graduate Equivalency
Certification (FPGEC) from the National Association of Boards of Pharmacy
Foundation Foreign Pharmacy Graduate Examination Committee. Potential
applicants shall pay all fees and comply with all application/certification
procedures required by the National Association of Boards of Pharmacy
Foundation Foreign Pharmacy Graduate Examination Committee.
(4) After receiving FPGEC, applicants shall
file an application for preliminary evaluation with the board. Applications
shall be submitted on a form provided by the board and accompanied by the
application fee. The preliminary evaluation application shall include:
(A) A copy of a certificate showing proof of
name, date of birth, and place of birth by one (1) of the following methods:
1. Birth certificate;
2. Baptismal certificate; or
3. Notarized statement from an authorized
governmental agency.
(B)
Documentation of name change, if the name on the credentials supplied for
evaluation purposes is different than the name appearing on the
application;
(C) Proof of
fingerprinting as required by
20 CSR
2220-7.090;
(D) A copy of the applicant's FPGEC
certificate;
(E) Proof of U.S.
citizenship or, if the applicant is not a U.S. citizen, a copy of current visa,
along with a copy of a U.S. employment authorization document such as an Alien
Registration Receipt Card, Form I-551 or Employment Authorization Card Form
I-688-B, or any other document approved or issued by the U.S. government
permitting employment in the U.S.; and
(F) Documentation as required by the board
showing proof of one thousand five hundred (1,500) hours of pharmacy practice
experience related to the practice of pharmacy or proof that the applicant has
maintained an active pharmacist license in another U.S. state/territory for a
period of not less than one (1) year. To be eligible for licensure, the one
thousand five hundred (1,500) hours of pharmacy practice experience must have
been earned in a U.S. state/territory after the date the applicant obtained
FPGEC certification. Applicants who have not yet completed the one thousand
five hundred- (1,500-) hour experience requirement shall apply for licen-sure
as an intern pharmacist and shall complete the required one thousand five
hundred (1,500) hours before the applicant's preliminary evaluation application
is approved.
(5)
Reciprocity/License Transfer. After the preliminary evaluation application has
been approved by the board, graduates of a foreign school/college that are
currently licensed in another U.S. state/territory shall be governed by, and
shall apply for licensure by license transfer/reciprocity pursuant to,
20 CSR
2220-7.050.
(6) Test Scheduling for Foreign Graduates
Applying for Licensure by Examination. When an application has been completed,
the board shall notify an applicant if he/she is eligible for the North
American Pharmacist Licensure Examination (NAPLEX) and/or Multistate Pharmacy
Jurisprudence Examination (MPJE) examinations. The applicant shall schedule
test dates for both the NAPLEX and MPJE with the National Association of Boards
of Pharmacy (NABP). The applicant shall satisfy all testing and scheduling
requirements established by NABP and shall complete any necessary
application(s) and payment of fee(s) for scheduling/taking the examination(s).
(A) To avoid forfeiture of eligibility, the
applicant must take the examination(s) within three hundred sixty-five (365)
days after having been determined eligible for examination by the board. If the
applicant does not take the examination within three hundred sixty-five (365)
days, the applicant shall be required to reapply to the board for
examina-tion/licensure and again pay the examination application fee.
(B) A determination by the board that an
applicant is eligible for examination does not guarantee that the applicant
will be issued a Missouri pharmacist license. The board reserves the right to
deny an applicant for licensure that has been approved to take the required
examinations as authorized by Missouri law.
(7) Testing. Applicants for licensure by
examination shall successfully pass both the NAPLEX and the MPJE examinations.
A minimum score of seventy-five (75) is required for each of the required
examinations. Upon approval by the board and successful completion of the
NAPLEX and MPJE, the board may issue a pharmacist license to the
applicant.
(8) Retesting. If an
applicant fails to achieve a score of seventy-five (75) on both the NAPLEX and
MPJE, the candidate shall retake and pass the failed examination(s) before a
license can be issued. Any applicant who fails to achieve a passing score on
either of the examinations shall file an application for reexamination with the
board and pay the examination application fee each time. All examinations are
scored independently and may be retaken independently.
(A) The board shall review and approve any
applicant that fails the NAPLEX or MPJE two (2) consecutive times prior to the
applicant being declared eligible to retest. A candidate shall not be declared
eligible to retest under this subsection until approved by the board. In lieu
of disapproval, the board may establish a date after which the candidate shall
be eligible to retest or may establish additional training or study
requirements to be completed before authorization to retest is
granted.
(B) Application for
reexamination shall be made on a form provided by the board. Fees for
reexamination shall be non-refundable.
(9) Upon approval by the board and successful
completion of the NAPLEX and MPJE, the board shall issue a pharmacist license
to the applicant.
(10) A
preliminary evaluation application shall be deemed invalid if the applicant
fails to submit all information required to complete the application within six
(6) months after the application is received by the board.
However, a preliminary evaluation application shall not be deemed invalid if the applicant has applied for licensure as a Missouri intern pharmacist to complete the required pharmacy practice experience and has completed all other preliminary application requirements, provided the application shall be deemed void if the applicant fails to complete the required pharmacy practice experience within two (2) years from the date the preliminary evaluation application was initially received by the board.
Notes
*Original authority: 338.020, RSMo 1939, amended 1947, 1949, 1981, 1990; 338.040, RSMo 1939, amended 1961, 1969, 1981, 1990; 338.060, RSMo 1939, amended 1943, 1947, 1949, 1951, 1981, 1984, 1997, 1999; 338.070, RSMo 1939, amended 1947, 1953, 1961, 1969, 1981, 1985, 1997; 338.035, RSMo 1990, amended 1993, 1995, 2007; and 338.140, RSMo 1939, amended 1981, 1989, 1997, 2011 .
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
PURPOSE: This rule establishes licensure requirements for pharmacist applicants who are graduates from a pharmacy school/college not located in the United States or a United States territory.
(1) Definitions.
(A) Foreign school/college-For purposes of this rule, a foreign school/college shall be defined as a school/college of pharmacy that is not located in a United States (U.S.) state/territory.
(B) Preliminary evaluation application- The Application for Preliminary Evaluation of Foreign Pharmacy School Graduate provided by the board for graduates of a foreign school/college.
(2) Applicability. The provisions of this rule are applicable to all graduates of a foreign school/college, including, graduates currently or previously licensed as a pharmacist by another U.S. state/territory. Graduates from a foreign school/college of pharmacy shall comply with the provisions of this rule prior to filing an examination application, an application for pharmacist licensure, or a reciprocity application.
(3) Prior to applying for pharmacist licen-sure/examination, graduates of a foreign school/college shall first obtain Foreign Pharmacy Graduate Equivalency Certification (FPGEC) from the National Association of Boards of Pharmacy Foundation Foreign Pharmacy Graduate Examination Committee. Potential applicants shall pay all fees and comply with all application/certification procedures required by the National Association of Boards of Pharmacy Foundation Foreign Pharmacy Graduate Examination Committee.
(4) After receiving FPGEC, applicants shall file an application for preliminary evaluation with the board. Applications shall be submitted on a form provided by the board and accompanied by the application fee. The preliminary evaluation application shall include:
(A) A copy of a certificate showing proof of name, date of birth, and place of birth by one (1) of the following methods:
1. Birth certificate;
2. Baptismal certificate; or
3. Notarized statement from an authorized governmental agency.
(B) Documentation of name change, if the name on the credentials supplied for evaluation purposes is different than the name appearing on the application;
(C) Proof of fingerprinting as required by 20 CSR 2220-7.090;
(D) A copy of the applicant 's FPGEC certificate;
(E) Proof of U.S. citizenship or, if the applicant is not a U.S. citizen, a copy of current visa, along with a copy of a U.S. employment authorization document such as an Alien Registration Receipt Card, Form I-551 or Employment Authorization Card Form I-688-B, or any other document approved or issued by the U.S. government permitting employment in the U.S.; and
(F) Documentation as required by the board showing proof of one thousand five hundred (1,500) hours of pharmacy practice experience related to the practice of pharmacy or proof that the applicant has maintained an active pharmacist license in another U.S. state/territory for a period of not less than one (1) year. To be eligible for licensure, the one thousand five hundred (1,500) hours of pharmacy practice experience must have been earned in a U.S. state/territory after the date the applicant obtained FPGEC certification. Applicants who have not yet completed the one thousand five hundred- (1,500-) hour experience requirement shall apply for licen-sure as an intern pharmacist and shall complete the required one thousand five hundred (1,500) hours before the applicant 's preliminary evaluation application is approved.
(5) Reciprocity/License Transfer. After the preliminary evaluation application has been approved by the board, graduates of a foreign school/college that are currently licensed in another U.S. state/territory shall be governed by, and shall apply for licensure by license transfer/reciprocity pursuant to, 20 CSR 2220-7.050.
(6) Test Scheduling for Foreign Graduates Applying for Licensure by Examination. When an application has been completed, the board shall notify an applicant if he/she is eligible for the North American Pharmacist Licensure Examination (NAPLEX) and/or Multistate Pharmacy Jurisprudence Examination (MPJE) examinations. The applicant shall schedule test dates for both the NAPLEX and MPJE with the National Association of Boards of Pharmacy (NABP). The applicant shall satisfy all testing and scheduling requirements established by NABP and shall complete any necessary application(s) and payment of fee(s) for scheduling/taking the examination(s).
(A) To avoid forfeiture of eligibility, the applicant must take the examination(s) within three hundred sixty-five (365) days after having been determined eligible for examination by the board. If the applicant does not take the examination within three hundred sixty-five (365) days, the applicant shall be required to reapply to the board for examina-tion/licensure and again pay the examination application fee.
(B) A determination by the board that an applicant is eligible for examination does not guarantee that the applicant will be issued a Missouri pharmacist license. The board reserves the right to deny an applicant for licensure that has been approved to take the required examinations as authorized by Missouri law.
(7) Testing. Applicants for licensure by examination shall successfully pass both the NAPLEX and the MPJE examinations. A minimum score of seventy-five (75) is required for each of the required examinations. Upon approval by the board and successful completion of the NAPLEX and MPJE, the board may issue a pharmacist license to the applicant .
(8) Retesting. If an applicant fails to achieve a score of seventy-five (75) on both the NAPLEX and MPJE, the candidate shall retake and pass the failed examination(s) before a license can be issued. Any applicant who fails to achieve a passing score on either of the examinations shall file an application for reexamination with the board and pay the examination application fee each time. All examinations are scored independently and may be retaken independently.
(A) The board shall review and approve any applicant that fails the NAPLEX or MPJE two (2) consecutive times prior to the applicant being declared eligible to retest. A candidate shall not be declared eligible to retest under this subsection until approved by the board. In lieu of disapproval, the board may establish a date after which the candidate shall be eligible to retest or may establish additional training or study requirements to be completed before authorization to retest is granted.
(B) Application for reexamination shall be made on a form provided by the board. Fees for reexamination shall be non-refundable.
(9) Upon approval by the board and successful completion of the NAPLEX and MPJE, the board shall issue a pharmacist license to the applicant .
(10) A preliminary evaluation application shall be deemed invalid if the applicant fails to submit all information required to complete the application within six (6) months after the application is received by the board.
However, a preliminary evaluation application shall not be deemed invalid if the
Notes
*Original authority: 338.020, RSMo 1939, amended 1947, 1949, 1981, 1990; 338.040, RSMo 1939, amended 1961, 1969, 1981, 1990; 338.060, RSMo 1939, amended 1943, 1947, 1949, 1951, 1981, 1984, 1997, 1999; 338.070, RSMo 1939, amended 1947, 1953, 1961, 1969, 1981, 1985, 1997; 338.035, RSMo 1990, amended 1993, 1995, 2007; and 338.140, RSMo 1939, amended 1981, 1989, 1997, 2011 .